Upgrade to SI Premium - Free Trial

Form 3 PFIZER INC For: Apr 01 Filed by: Hancock Dennis P

April 10, 2026 1:11 PM
FORM 3 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0104
Expires: December 31, 2014
Estimated average burden
hours per response: 0.5
1. Name and Address of Reporting Person *
Hancock Dennis P
(Last) (First) (Middle)
66 HUDSON BOULEVARD EAST
ATTN: CORPORATE SECRETARY
(Street)
NEW YORK NY 10001-2192
(City) (State) (Zip)
2. Date of Event Requiring Statement (Month/Day/Year)
04/01/2026 		3. Issuer Name and Ticker or Trading Symbol
PFIZER INC [ PFE ]
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
Senior Vice President
 5. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4) 2. Amount of Securities Beneficially Owned (Instr. 4) 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock 45,097
D
Table II - Derivative Securities Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4) 2. Date Exercisable and Expiration Date (Month/Day/Year) 3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) 4. Conversion or Exercise Price of Derivative Security 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 6. Nature of Indirect Beneficial Ownership (Instr. 5)
Date Exercisable Expiration Date Title Amount or Number of Shares
Stock Appreciation Rights 03/04/2030 (1) 03/04/2030 (1) Common Stock 33,051 25.75 D
Stock Appreciation Rights 03/03/2031 (1) 03/03/2031 (1) Common Stock 15,748 26.58 D
Stock Appreciation Rights 02/27/2029 (1) 02/27/2029 (1) Common Stock 13,430 26.89 D
Stock Appreciation Rights 02/27/2031 (2) 02/27/2031 (2) Common Stock 11,867 26.89 D
Stock Appreciation Rights 02/27/2027 (2) 02/27/2027 (2) Common Stock 9,603 31.31 D
Stock Appreciation Rights 02/25/2028 (2) 02/25/2028 (2) Common Stock 9,102 33.82 D
Stock Appreciation Rights 02/23/2030 (2) 02/23/2030 (2) Common Stock 7,493 42.3 D
Stock Appreciation Rights 02/23/2030 (1) 02/23/2030 (1) Common Stock 8,610 42.3 D
Stock Appreciation Rights 02/24/2029 (2) 02/24/2029 (2) Common Stock 6,040 45.96 D
Stock Appreciation Rights 02/24/2029 (1) 02/24/2029 (1) Common Stock 6,868 45.96 D
Explanation of Responses:
1. The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the fifth anniversary of the date of grant.
2. The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the seventh anniversary of the date of grant.
/s/ Shanice A. Reid, by Power of atty, for Dennis P. Hancock 04/10/2026
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Categories

SEC Filings